American Heart Journal

Article	Citations
Association of Increased Fructose Consumption with Atrial Fibrillation Symptoms	145
Risk of delayed percutaneous coronary intervention for STEMI in the Southeast United States	144
Differences in Clinical Outcomes Between Non-Obese Caucasian and African American Populations Who Have Diabetes, A Nation-Wide Study	82
Table of Contents	79
Table of Contents	72
Evaluation of Huawei smart wearables for detection of atrial fibrillation in patients following ischemic stroke: The Liverpool-Huawei stroke study	67
Non-Adherence to Antihypertensive Medications Among the US Population: A Pooled Analysis of 22 Million Patients	61
Differences in incident and recurrent myocardial infarction among White and Black individuals aged 35 to 84: Findings from the ARIC community surveillance study	56
Physician responses to apple watch-detected irregular rhythm alerts	45
Editorial Board	45
Impact of vomiting on P2Y12 platelet inhibition in patients with ST-elevation myocardial infarction: A prespecified subanalysis of the ON-TIME 3 trial	45
Rationale and design of the NODE-303 study: evaluating the safety of symptom-prompted, self-administered etripamil for paroxysmal supraventricular tachycardia episodes in real-world settings	45
In vivo evidence of atherosclerotic plaque erosion and healing in patients with acute coronary syndrome using serial optical coherence tomography imaging	40
Information for Readers	37
The rationale, design, and methods of a trial to evaluate the efficacy and safety of oxygen therapy in patients with intermediate-risk acute pulmonary embolism	34
Accuracy of Diagnosing Diabetic Ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and DKA-HHS: The Significance for Cardiac Function	34
Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: A randomized clinical trial	33
Operational challenges and mitigation measures during the COVID-19 pandemic–Lessons from DELIVER	32
Information for Readers	32
Nationwide Utilization of Danish Government Electronic letter system for increasing inFLUenza vaccine uptake (NUDGE-FLU): Study protocol for a nationwide randomized implementation trial	32
Different dose aspirin plus immunoglobulin (DAPI) for prevention of coronary artery abnormalities in Kawasaki disease: Study protocol for a multi-center, prospective, randomized, open-label, blinded e	32
Absence of coronary artery disease in patients undergoing coronary imaging and association with amyloidosis: A Danish nationwide study	31
Heart failure and nocturnal hypoxemic burden, the connection is getting closer and closer	30
Rationale and design of NUDGE-CKD: A nationwide randomized factorial trial of electronic nudges for increasing guideline-directed medical therapy in chronic kidney disease	30
Accuracy of instantaneous wave-free ratio and fractional flow reserve derived from single coronary angiographic projections	30

Cardiac auscultation skills among medical trainees	30
The trial to assess chelation therapy 2 (TACT2): Rationale and design	30
Malignant left ventricular hypertrophy and risk of cognitive impairment in SPRINT MIND trial	29
Diagnostic performance of a novel automated CT-derived FFR technology in detecting hemodynamically significant coronary artery stenoses: A multicenter trial in China	27
Editorial Board	27
COMPARE LAAO: Rationale and design of the randomized controlled trial “COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at hig	27
Diagnostic and prognostic impact of new pathophysiology-based categorization of type 1 and type 2 myocardial infarction: data from the French RICO survey	27
Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trial	27
Information for Readers	26
Editorial Board	25
Table of Contents	24
Longer term benefits of exercise and escitalopram in the treatment of anxiety in patients with coronary heart disease: Six month follow-up of the UNWIND randomized clinical trial	24
Ambulatory inotropic therapy: To what end?	24
Rationale and design of the Dynamic Coronary Roadmap for Contrast Reduction (DCR4Contrast) in PCI randomized controlled trial	24
The “Great Wave”: Childhood Obesity and Overweight	24
Rheumatoid Arthritis and the Connection with Cardiovascular Disease Mortality	24
Prospective randomized comparison between upgraded ‘2C3L’ vs. PVI approach for catheter ablation of persistent atrial fibrillation: PROMPT-AF trial design	24
Impact of moderate or severe mitral and tricuspid valves regurgitation after transcatheter aortic valve replacement	23
Adipose tissue n-3/n-6 fatty acids ratios versus n-3 fatty acids fractions as predictors of myocardial infarction	23
Single Nucleotide Variants of the MCM6 Gene as a Risk Factor for Metabolically Unhealthy Obesity in Children	23
Obicetrapib Does Not Accumulate in Adipose Tissue: Results from Studies in Man and Non-Human Primates	22
Clinical Data and Diagnostic findings in Patients with Ischemic Heart Disease undergoing Coronary Angiography: a Cross-sectional study from a Tertiary Hospital in Sudan, Africa	22
Diversity of electrocardiographic patterns in left main culprit acute ST-elevation myocardial infarction	22
The incremental role of late gadolinium enhancement in risk stratifying high risk patients with hypertrophic cardiomyopathy	21
Premorbid physical activity and prognosis after incident myocardial infarction: The atherosclerosis risk in communities study	21
Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinica	21
The pediatric heart network's study on long-term outcomes of children with HLHS and the impact of Norwood Shunt type in the single ventricle reconstruction trial cohort (SVRIII): Design and adaptation	20
Chest pain and coronary artery disease in cardiac amyloidosis: Prevalence, mechanisms, and clinical implications	20
Prehospital treatment with zalunfiban (RUC-4) in patients with ST‐ elevation myocardial infarction undergoing primary percutaneous coronary intervention: Rationale and design of the CELEBRATE trial	20
Implementing remote patient monitoring to improve hypertension control in a primary care network: Rationale and design of the monitor-BP Cluster Randomized Trial	20
Pursuing functional biomarkers in complex disease: Focus on pulmonary arterial hypertension	20
Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry	20
Implementing guideline-directed medical therapy: Stakeholder-identified barriers and facilitators	20
Edoxaban-based long-term antithrombotic therapy in patients with atrial fibrillation and stable coronary disease: Rationale and design of the randomized EPIC-CAD trial	19
Lipoprotein(a) immunoassays and their associations with coronary artery calcification and aortic valve calcification	19
Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial	18
Corrigendum to ``Transcoronary cooling and dilution for cardioprotection during revascularisation for ST-segment elevation myocardial infarction: design and rationale of the STEMI-Cool study''. [Am He	18
Differences in guideline directed medical therapy for rural and non-rural Veterans with heart failure with reduced ejection fraction	18
Hypocholesterolemic Effect of Avocado (Persea americana Mill) Juice in Hypercolestrolemic Rats Model	18
Encouraging the prescribing of SGLT2i and GLP-1RA medications to reduce cardiovascular and renal risk in patients with type 2 diabetes: Rationale and design of a randomized controlled trial	18
Rationale and design of BROKEN-SWEDEHEART: a registry-based, randomized, parallel, open-label multicenter trial to test pharmacological treatments for broken heart (takotsubo) syndrome	18
Editorial Board	18
Shortening the duration of dual antiplatelet therapy after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis	18
Results from a Randomized, Open-Label, Crossover Study Evaluating Pharmacokinetic Interaction Between the Aldosterone Synthase Inhibitor Baxdrostat and Metformin in Healthy Human Subjects	17
Trends in outcomes and resource utilization for acute myocardial infarction admissions during the COVID-19 pandemic	17
Predicting short-term outcomes after transcatheter aortic valve replacement for aortic stenosis	17
Prognostic impact of quantitative flow ratio (QFR)-consistent complete revascularization in patients with myocardial infarction and multivessel coronary artery disease	17
Editorial Board	17
Efficacy of Liraglutide Versus Gliclazide in Treatment of Patients with Type II Diabetes Mellitus: Systematic Review and Meta-Analysis	17
Tricuspid valve disease prevalence and the impact of tricuspid valve surgery on cardiovascular events and hospital resource use in medicare beneficiaries	17

Type 1 diabetes and oxidative stress markers	17
High Glucose Suppresses Cardiomyocyte Progenitor Cell Regenerative Capacity and the Role of miR-195/EZH2 Crosstalk in Gestational Diabetes Mellitus	17
Inflammation biomarkers and incident coronary heart disease: the Reasons for Geographic And Racial Differences in Stroke Study	16
Impact of a clinical atrial fibrillation risk estimation tool on cardiac rhythm monitor utilization following acute ischemic stroke: A prepost clinical trial	16
Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria	16
Early detection of obstructive coronary artery disease in the asymptomatic high-risk population: objectives and study design of the EARLY-SYNERGY trial	16
Information for Readers	16
ISCHEMIA-EXTEND studies: Rationale and design	16
Perioperative bleeding and outcomes after noncardiac surgery	16
Development of a unified national database of primary percutaneous coronary intervention centers with co-located emergency departments, 2020	16
Cardiovascular risk factor profiles in North and South Indian and Pakistani Americans: The MASALA Study	16
Clinical Outcomes in Non-Obese Caucasian and Hispanic Populations with DM, a Nation-Wide Study	15
Benefits of Fiber-Rich Snacks on Waist Circumference and Atergenic Index of Plasma in Obese	15
Surrogate markers of gut dysfunction are related to heart failure severity and outcome–from the BIOSTAT-CHF consortium	15
Gamification-augmented home-based exercise for peripheral artery disease: Rationale and design of the GAMEPAD Study	15
Towards a person-centered after-visit summary to facilitate improved heart failure care (HF-AVS): A scoping review and call to action	15
Deploying a novel custom mobile application for STEMI activation and transfer in a large healthcare system to improve cross-team workflow. STEMIcathAID implementation project	15
Estimate Patient's 10-Years Cardiovascular Risk using Arteriosclerotic Cardiovascular Disease Tool a Cross-Sectional Study in Al-Harja, Asser, Saudi Arabia, 2021	15
Effect of colchicine on progression of known coronary atherosclerosis in patients with STable CoROnary artery disease CoMpared to placebo (EKSTROM) trial—rationale and design	15
Editorial Board	15
Distal versus conventional radial access for coronary angiography and intervention: Design and rationale of DISCO RADIAL study	15
Information for Readers	14
Information for Readers	14
Prognostic value of echocardiography for heart failure and death in adults with chronic kidney disease	14
The Relationship Between Glycemia and Heart Failure in Patients with Coronary Heart Disease and Diabetes Mellitus 2	14
Pragmatic trial of messaging to providers about treatment of acute heart failure: The PROMPT-AHF trial	14
Rationale and design of the direct oral anticoagulants for prevention of left ventricular thrombus after anterior acute myocardial infarction (APERITIF) trial	14
Familial Hypercholesterolemia and Type 2 Diabetes: Diagnostic and Therapeutic Challenges	14
Influence of left ventricular ejection fraction in patients undergoing contemporary pLVAD-supported high-risk PCI	14
Advancement of the implementation of evidence-based therapies for cardiovascular-kidney-metabolic conditions: A multi-stakeholder perspective	13
The Role of Dialysis in Outcomes of LVAD Implantation in Chronic Kidney Disease Patients: Insights from US National Readmission Database	13
Mortality and rehospitalization after mitral valve surgery as a function of age and key comorbidities	13
Patterns of diuretic titration during inpatient management of acute decompensated heart failure	13
Framework of the strengths and challenges of clinically integrated trials: An expert panel report	13
Table of Contents	13
Design and rationale of a pragmatic randomized clinical trial of early dronedarone versus usual care to change and improve outcomes in persons with first-detected atrial fibrillation – the CHANGE AFIB	13
Association of change in QRS duration with chronic heart failure outcomes	13
Bimodal distribution of atrial fibrillation burden in 3 distinct cohorts: What is ‘paroxysmal’ atrial fibrillation?	13
Days alive out of hospital in heart failure: Insights from the PARADIGM-HF and CHARM trials	13
Transcatheter aortic‐valve implantation with or without on‐site cardiac surgery: The TRACS trial	13
Rationale and design of the early valve replacement in severe asymptomatic aortic stenosis trial	13
Dyslipidaemia Patterns and Risk Factors Among Patients with Diabetes, Hypertension, and Both Diabetes and Hypertension at a Tertiary Hospital in Malawi	13
Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure	13
Patient characteristics, treatment patterns, and prognosis in drug-use-associated infective endocarditis in Denmark from 1999 to 2018	13
Tailored hydration for the prevention of contrast-induced acute kidney injury after coronary angiogram or PCI: A systematic review and meta-analysis	13
Association of testosterone-induced increase in neutrophil and monocyte counts with thromboembolic events: The TRAVERSE trial	13
Influence of Prediabetes on Coronary Atherosclerotic Plaque Burden Assessed by Coronary Computed Tomography Angiography (CCTA).	13
Bempedoic Acid for Management of Dyslipidemia from an Indian Perspective: An Expert Consensus Report	13
Plasma proteomics for prediction of subclinical coronary artery calcifications in primary prevention	13
Rationale and design of a cluster-randomized pragmatic trial aimed at improving use of guideline directed medical therapy in outpatients with heart failure: PRagmatic trial of messaging to providers a	12
Prognostic Value of Triglyceride-Glucose Index for the Prediction of Cardiovascular Events: Results from the Multi-Ethnic Study of Atherosclerosis (MESA)	12
Dysglycemia and incident heart failure among blacks: The jackson heart study	12
Strategy to optimize PeriproCeduraL AnticOagulation in structural transseptal interventions: Design and rationale of the STOP CLOT trial	12
Prevalence and prognostic significance of ischemic late gadolinium enhancement pattern in non-ischemic dilated cardiomyopathy	12
Editorial Board	12
Distinct triglyceride-glucose trajectories are associated with different risks of incident cardiovascular disease in normal-weight adults	12
Comparative effectiveness and healthcare utilization for ambulatory cardiac monitoring strategies in Medicare beneficiaries	12
Potassium-competitive acid blocker vs proton-pump inhibitor in patients receiving antithrombotic therapy who are at high risk for gastrointestinal bleeding: Rationale and design of the randomized PROT	12
Coarctation of aorta is associated with left ventricular stiffness, left atrial dysfunction and pulmonary hypertension	12
Anatomic and physiologic classification of adults with congenital heart disease to predict adverse outcomes: Use of administrative codes compared to clinical staging	12
Physician assessment of aortic stenosis severity, quantitative parameters, and long-term outcomes: Results from the KP-VALVE project	12
Editorial Board	12
Complete revascularization versus culprit-lesion only PCI in patients with NSTEMI and multivessel disease – Design and rationale of the randomized COMPLETE-NSTEMI trial	12
Sex differences in emergency medical services management of patients with myocardial infarction: analysis of routinely collected data for over 110,000 patients	12
Danish-German cardiogenic shock trial—DanGer shock: Trial design update	12
Sex-differences in 5 year Survival with Percutaneous Coronary Intervention Compared to Coronary Artery Bypass Graft surgery in patients with Diabetes and Multivessel Disease	12
Association between visit frequency, continuity of care, and pharmacy fill adherence in heart failure patients	12
Relationship Between Vaccines Against Coronavirus Disease 2019 (Covid-19) and Myocarditis	11
Race, hypertensive disorders of pregnancy and outcomes in peripartum cardiomyopathy	11
Rate versus rhythm control in patients with newly diagnosed atrial fibrillation: Effects of the treatment timing on health status outcomes	11
Self-Medication Practices from the Perspective of Tunisian Cardiovascular Patients – A Community Pharmacy-Based Survey	11
The Effect of Avocado Drink (Persea Americana Mill) on the Incidence of Ballooning Hepatocyte in the Liver Organs of Rats (Rattus Novergicus) Induced by Hypercholesterolemia	11
Table of Contents	11
Editorial Board	11
Transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis aged 70 years or younger: A NOTION-2 substudy	11
Lactate Dehydrogenase can be Considered a Predictive Marker of Severity and Mortality of Covid-19 in Diabetic and Non-Diabetic Patients. A Case Series	11
Effect of tirzepatide on the progression of coronary atherosclerosis using MDCT: Rationale and design of the tirzepatide treatment on coronary atherosclerosis progression: The (T-Plaque) randomized-co	11
Information for Readers	11
Single Nucleotide Variants of the VDR Gene and Cardiometabolic Risk in Obesity	10
Table of Contents	10

Randomized controlled trial of urinE chemiStry guided aCute heArt faiLure treATmEnt (ESCALATE): Rationale and design	10
Rationale and Design of the Groningen Intervention Study for the Preservation of Cardiac Function with Sodium Thiosulfate after St-segment Elevation Myocardial Infarction (GIPS-IV) trial	10
OCEAN trial update	10
Association of kidney function and atrial fibrillation progression to clinical outcomes in patients with cardiac implantable electronic devices	10
Editorial Board	10
Rationale for and design of a multicenter, placebo-controlled, phase 3 study to assess efficacy and safety of intranasal etripamil for the conversion of paroxysmal supraventricular tachycardia	10
Risk Scale for Patients with Newly Diagnosed Diabetic Foot Ulcer - Which Patients May Experience Healing Failure or Need Revascularization	10
Does targeted positioning of the left ventricular pacing lead towards the latest local electrical activation in cardiac resynchronization therapy reduce the incidence of death or hospitalization for h	10
Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design	10
EVALUATION OF NEUTROPHIL-LYMPHOCYTE RATIO IN DIABETES AND CORONARY ARTERY DISEASE: A CASE CONTROL STUDY FROM INDIA	10
Overview of 2024 FDA Advisory Panel Meeting on the TriClip transcatheter tricuspid valve repair system	10
On-treatment blood pressure and cardiovascular mortality in adults with repaired coarctation of aorta	10
Transcatheter edge-to-edge repair for chronic functional mitral regurgitation in patients with very severe left ventricular dysfunction	10
The effect of tablet computer-based telemonitoring added to an established telephone disease management program on heart failure hospitalizations: The Specialized Primary and Networked Care in Heart F	10
Challenges of long-term dual antiplatelet therapy use following acute coronary syndromes	10
Effects of complete revascularization according to age in patients with ST-segment elevation myocardial infarction and multivessel disease (COMPLETE-AGE)	10
Patients Admitted with Metabolic Syndrome and Atrial Fibrillation Have Greater Risk of Adverse Cardiovascular Events and Clinical Outcomes	10
Rationale and design of the colchicine for the prevention of perioperative atrial fibrillation in patients undergoing major noncardiac thoracic surgery (COP-AF) trial	10
Use of e-cigarettes, traditional combustible cigarettes, and high sensitivity C-reactive protein: The Cross Cohort Collaboration	10
Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet	10
A randomized embedded multifactorial adaptive platform for extra corporeal membrane oxygenation (REMAP ECMO) – design and rationale of the left ventricular unloading trial domain	10
Investigating the Smoker's Paradox: Aortic Stenosis Patient Outcomes in Smokers	10
Central Venous Access: Conventional Seldinger Versus Ultrasound-Guided Technique to Reduce Associated Complications in A School Hospital	9
Study protocol and baseline characteristics of Randomized trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy–Statin and Eicosapentaenoic Acid: RESPECT-EPA, the combination of	9
Predictors of Major Adverse Limb Events After Infrainguinal Bypass in Patients with Diabetes	9
Design, rationale, and characterization of the mobile health based occupational cardiovascular risk intervention study (mHealth-OPEN study)	9
Rationale and design of the multicentric randomized EVAOLD trial: Evaluation of a strategy guided by imaging versus routine invasive strategy in elderly patients with ischemia	9
Contemporary laboratory assessment of acute cardiorenal syndrome for early diagnosis: A call for action	9
Characterization of peripheral artery disease and associations with traditional risk factors, mobility, and biomarkers in the project baseline health study	9
Incorporating Ensembled Stacked Approach into Automated Machine Learning in an Attempt to Predict Acute Ischemic Heart Disease in Patients with Atypical Chest Pain: Secondary Analysis of a Single-Cent	9
Meta‐analysis assessing the sensitivity and specificity of 18F‐FDG PET/CT for the diagnosis of prosthetic valve endocarditis (PVE) using individual patient data (IPD)	9
Obicetrapib Alone and in Combination with Ezetimibe Reduces Atherosclerotic Lesion Prevalence, Size and Severity in ApoE*3-Leiden.CETP Mice	9
Rationale and design for the study of recombinant human hepatocyte growth factor plasmid in the treatment of patients with chronic limb-threatening ischemia (HOPE CLTI): Randomized, placebo-controlled	9
Computerized clinical decision support to improve stroke prevention therapy in primary care management of atrial fibrillation: a cluster randomized trial	9
Cardiovascular risk and outcomes in symptomatic patients with suspected coronary artery disease and non coronary vascular disease: A report from the PROMISE trial	9
Prognosis of patients with nonspecific electrocardiogram findings in a Tanzanian emergency department	9
Editorial Board	9
Table of Contents	9
Pregnancy in women with congenital heart disease: New insights into neonatal risk prediction	9
Comparing the outcomes of rheumatic heart disease in pregnancy complicated with and without atrial fibrillation: A propensity score matched analysis	9
Prediction of early death after atrial fibrillation diagnosis using a machine learning approach: A French nationwide cohort study	9
Editorial Board	9
Achievement of LDL-C <55 mg/dL among US adults: Findings from the cvMOBIUS2 registry	8
Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease	8
Fibroblast growth factor-23 and subclinical markers of cardiac dysfunction: The coronary artery risk development in young adults (CARDIA) study	8
A randomized clinical trial of catheter ablation and antiarrhythmic drug therapy for suppression of ventricular tachycardia in ischemic cardiomyopathy: The VANISH2 trial	8
Ultrathin-strut vs thin-strut drug-eluting stents for multi and single-stent lesions: A lesion-level subgroup analysis of 2 randomized trials	8
Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation	8
The coronary microvascular angina cardiovascular magnetic resonance imaging trial: Rationale and design	8
The prognostic significance of single-lead ST-segment resolution in ST-segment elevation myocardial infarction patients treated with primary PCI – A substudy of the randomized TOTAL trial	8
Hidden in Plain Sight: The Association of Cystic Fibrosis and Diabetic Ketoacidosis- A Nationwide Study	8
A randomized trial of antithrombotic therapy in patients with acute coronary syndrome and coronary ectasia	8
Novel automated electronic medical record-based VEST (virtual echocardiography screening tool) algorithm for pulmonary arterial hypertension	8
Editorial Board	8
Could paramedics use the HEART Pathway to identify patients at low-risk of myocardial infarction in the prehospital setting?	8
Editorial Board	8
The relative merits of using a high-sensitivity cardiac Troponin T assay compared to a nonhigh-sensitivity troponin T assay after noncardiac surgery	8
Protocol for a novel sodium and blood pressure reduction intervention targeting online grocery shoppers with hypertension – the SaltSwitch Online Grocery Shopping randomized trial	8
Table of Contents	8
Quality and rapidity of anticoagulation in patients with acute pulmonary embolism undergoing mechanical thrombectomy	8
The Use of Extracorporeal Membrane Oxygenation (ECMO) and Protective Mechanical Ventilation in the Treatment of Acute Respiratory Failure	8
Prevalence and clinical correlates and characteristics of “Super Fontan”	8
The pathophysiology of patent foramen ovale and its related complications	8
The ENHANCE-AF clinical trial to evaluate an atrial fibrillation shared decision-making pathway: Rationale and study design	8
Emergency department visits and hospitalizations after a diagnosis of angina with no obstructive coronary artery disease (ANOCA)	8
Enrollment strategies in the era of digital revolution: Experience from a remote health management program	8
Biomarkers in Determining the Risk of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Hypertension	8
The randomized controlled trial to compare temporary permanent pacemaker vs temporary pacemaker in patients with conduction block after transcatheter aortic valve replacement: Rationale and design of	8
Association of sex with in-hospital management and outcomes of patients with heart failure: Data from the REAL-HF registry	8
Physicians' perspectives on percutaneous left atrial appendage occlusion for patients with atrial fibrillation	8
Information for Readers	8
The contemporary cardio-obstetrics team: The path to improving maternal outcomes in high-risk patients	8
Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trial	8
Text messages for primary prevention of cardiovascular disease: The TextMe2 randomized clinical trial	8
Inotrope versus placebo therapy in cardiogenic shock: Rationale and study design of the CAPITAL DOREMI2 trial	8
Baseline characteristics including blood and urine metal levels in the Trial to Assess Chelation Therapy 2 (TACT2)	8
Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design	8
Information for Readers	8
Information for Readers	7
Prognosis of elderly non-valvular atrial fibrillation patients stratified by B-type natriuretic peptide: ELDERCARE-AF subanalysis	7
Diabetes Mellitus and Peripartum Cardiomyopathy: A Nationwide Study	7
Zofenopril Treatment Efficacy on Survival, Endostatin and Insulin-Like Growth Factor-1 in Patients with Diabetes Mellitus Type 2 After Acute Myocardial Infarction	7
Study protocol for the healthy family program on population blood pressure: A multicenter, parallel group, cluster randomized, controlled trial in rural China	7
Study design and rationale for the Olpasiran trials of Cardiovascular Events And lipoproteiN(a) reduction-DOSE finding study (OCEAN(a)-DOSE)	7
at onal anish endocarditis st die – Design and objectives of the NIDUS registry	7
Balance of benefit and risk of ticagrelor in patients with diabetes and stable coronary artery disease according to bleeding risk assessment with the CRUSADE score: Data from THEMIS and THEMIS PCI	7
NOX Subunit Gene Polymorphisms and the Risk of Chronic Artery Disease in Type 2 Diabetes Patients	7
Long-term mortality in asymptomatic patients with stable ischemic heart disease undergoing percutaneous coronary intervention	7
Microalbuminuria in Patients with Type 2 Diabetes Mellitus Treated with a Phytoformula as Adjuvant.	7
Telomere, Telomerase and The Aging Heart	7
Hospital-level variation in cardiac rehabilitation metrics	7
Percutaneous mitral annuloplasty with the Carillon device: Outcomes in proportionate and disproportionate functional mitral regurgitation	7
Obicetrapib Demonstrates Significant Deductions of LP(A) on Top of High-Intensity Statins	7
REGENERATE-COBRA: A phase II randomized sham-controlled trial assessing the safety and efficacy of intracoronary administration of autologous bone marrow-derived cells in patients with refractory angi	7
Development and validation of an automated algorithm for end point adjudication for a large U.S. national registry	7